XML 54 R2.htm IDEA: XBRL DOCUMENT v2.4.0.8
Consolidated Balance Sheets (USD $)
In Thousands, unless otherwise specified
Sep. 30, 2014
Dec. 31, 2013
Current assets    
Cash and cash equivalents $ 813,468 $ 461,301
Marketable Securities, Current 0 239,388
Accounts receivable, net 592,964 428,457
Inventories 500,552 471,879
Prepaid expenses and other current assets 18,884 13,888
Deferred income taxes 26,080 34,169
Total current assets 1,951,948 1,649,082
Property, plant and equipment, net 2,710,475 2,088,014
Equity investments 70,828 66,875
Other assets, net    
Intangible assets, net 222,728 159,046
Deferred charges and other assets 170,304 97,892
Total other assets, net 393,032 256,938
Total assets 5,126,283 4,060,909
Current liabilities    
Accounts payable 263,365 249,613
Accrued liabilities 309,671 155,245
Total current liabilities 573,036 404,858
Long-term debt 763,968 763,879
Deferred income taxes 513,773 437,976
Other liabilities 153,158 35,593
Total liabilities 2,003,935 1,642,306
Commitments and contingencies (Notes 7 and 15)      
Stockholders' equity    
Preferred stock, $0.01 par value, 50,000,000 shares authorized; no shares issued and outstanding 0 0
Common stock, $0.01 par value, 300,000,000 shares authorized; 134,680,164 and 134,580,208 shares issued at September 30, 2014 and December 31, 2013, respectively (Note 1) 1,347 1,346
Common stock, held in treasury, at cost; 1,220,544 and 1,252,922 shares at September 30, 2014 and December 31, 2013, respectively (Note 1) (53,248) (46,220)
Additional paid-in capital 527,992 511,432
Retained earnings 2,394,203 1,954,661
Accumulated other comprehensive loss (36,433) (2,616)
Total Westlake Chemical Corporation stockholders' equity 2,833,861 2,418,603
Noncontrolling interests 288,487 0
Total equity 3,122,348 2,418,603
Total liabilities and equity $ 5,126,283 $ 4,060,909